Outpatient Versus Inpatient Balloon Catheter Induction of Labor

June 5, 2020 updated by: Turku University Hospital

Outpatient Versus Inpatient Double Balloon Catheter for Induction of Labor: a Randomised Trial

Randomized trial comparing double balloon catheter for induction of labor between in- and outpatient groups.Investigators assess feasibility, clinical effectiveness and patient acceptability of outpatient versus inpatient catheter for induction of labor.

Study Overview

Detailed Description

The objective of this study is to describe labor outcomes in women with double balloon induction catheter of labor. Participants included are women with uncomplicated singleton pregnancy of ≥37- ≤41+5 weeks of gestation. Patients are randomized to two groups: one hundred are randomized to the inpatient and one hundred to the outpatient group.

The main outcome measure is the pain evaluated by VAS at one, five, nine and 13 hours after the placement of double balloon induction catheter. The total hospital stay and induction to delivery interval time is measured. Also the mode of birth as well as maternal and neonatal morbidity and patient satisfaction are recorded.

Study Type

Interventional

Enrollment (Actual)

117

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Turku, Finland, 20520
        • Turku University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • uncomplicated pregnancy
  • singleton pregnancy
  • pregnancy weeks between >37 and <41+5
  • the patient is living in 1/2 hour away from hospital

Exclusion Criteria:

  • patient has any disease or medication
  • multiple pregnancy
  • pregnancy week > 41+5
  • preterm rupture of membranes
  • patient living more than 1/2 hour away from hospital

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Outpatient group
After insertion of double balloon induction catheter of labor, women are discharged overnight to home. Intervention is to let patient to go home.
Intervention is to let patient to go home.
Other: Inpatient group
After insertion of double balloon induction catheter of labor, women are observed in the prenatal ward. Intervention is to observe women in the ward.
Intervention is to observe women in the ward.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The pain measured by visual analogy scale(VAS) after double balloon catheter
Time Frame: During the induction of the labor and postpartum period in the hospital.
Visual analogy score assessed by patient. Minimum 1mm to maximum 100 mm.
During the induction of the labor and postpartum period in the hospital.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The maternal morbidity
Time Frame: during the induction of the labor and postpartum period in the hospital
number of mothers having any kind of infection
during the induction of the labor and postpartum period in the hospital
The total hospital stay in both groups
Time Frame: maximum 14 days
length in days
maximum 14 days
neonatal morbidity
Time Frame: during the induction of the labor and postpartum period in the hospital
number of babies having any kind of infection
during the induction of the labor and postpartum period in the hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Kirsi M Rinne, PhD, Turku University Hospital
  • Study Director: Päivi ML Polo, PhD, Turku University Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2016

Primary Completion (Actual)

December 30, 2019

Study Completion (Actual)

December 30, 2019

Study Registration Dates

First Submitted

June 3, 2016

First Submitted That Met QC Criteria

June 3, 2016

First Posted (Estimate)

June 8, 2016

Study Record Updates

Last Update Posted (Actual)

June 9, 2020

Last Update Submitted That Met QC Criteria

June 5, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • T169/2016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

Letter to patients.

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prolonged Pregnancy

Clinical Trials on Intervention is to let patient to go home.

3
Subscribe